Harry Lamble
Plus aucun poste en cours
Postes actifs de Harry Lamble
| Sociétés | Poste | Début | Fin |
|---|
Historique de carrière de Harry Lamble
Anciens postes connus de Harry Lamble
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Sense Biodetection Ltd.
 Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2014 | 30/01/2023 |
| Directeur Général | 01/01/2014 | 20/07/2021 | |
| Fondateur | 01/01/2014 | 30/01/2023 | |
| Corporate Officer/Principal | 20/07/2021 | 30/01/2023 | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Directeur/Membre du Conseil | 17/12/2009 | - |
| Secrétaire Général | - | - |
Formation de Harry Lamble
| University of Bath | Doctorate Degree |
| Cranfield University | Masters Business Admin |
Statistiques
Internationale
| Royaume-Uni | 5 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Sense Biodetection Ltd.
Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Health Services |
- Bourse
- Insiders
- Harry Lamble
- Expérience
